Tag: ASX:MXC

December 3, 2019

MGC Pharmaceuticals Receives Approval for Distribution in Ireland

MGC Pharmaceuticals has received formal approval from the Health Products Regulatory Authority (HPRA) in Ireland for the sale of CannEpil.
November 27, 2019

MGC Pharma Sees Growth in Prescriptions for November

MGC Pharmaceuticals announced it has seen 40 percent growth since the end of October 2019 in the number of prescribed...
November 19, 2019

A Guide to Investing in Malta’s Medical Cannabis Market

INN takes a look at Malta medical cannabis market and the role it could play within the European and international...
November 13, 2019

MGC Pharma Receives First Government Grant for Clinical Trial

MGC Pharma announced it's received government funding for its clinical trial with the University of Notre Dame Western Australia.
November 5, 2019

MGC Pharma Posts Quarterly Update

MGC Pharmaceuticals shared with investors its financial report for its most recent quarter.
October 31, 2019

MGC Pharmaceuticals Reports Update on LSE Listing

MGC Pharmaceuticals announced an increase in patient numbers and reported progress on its LSE listing in its September quarterly report.
October 30, 2019

MGC Pharmaceuticals Sets Date for Annual General Meeting

MGC Pharmaceuticals issued a notice for its annual general meeting set to take place on November 29, 2019.